Ledger.Open graph →
SEC Form D · filed December 17, 2014

Can-Fite BioPharma Ltd

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PETACH TIKVA, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Motti Farbstein · Petach Tikva, L3Exec · DirectorGil Oren · Petach Tikva, L3DirectorIlan Cohn · Petach Tikva, L3DirectorAbraham Sartini · Petach Tikva, L3DirectorGuy Regev · Petach Tikva, L3DirectorYechezkel Barenholz · Petach Tikva, L3DirectorPnina Fishman · Petach Tikva, L3Exec · DirectorDale J. Klein · Fargo, NDDirectorKevin J. Ritterman · Fargo, NDExec · DirectorRandall W. Moreadith · Huntsville, ALDirectorBarbara M. Fisk · Madison, ALDirectorMichael D. Bentley · Huntsville, ALDirectorJames R. Hudson, Jr · Huntsville, ALDirectorTacey R. Viegas · Madison, ALExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗